Papageorgiou, N; Providência, R; Falconer, D; Wongwarawipat, T; Tousoulis, D; Lim, WY; Chow, AW; ... Lambiase, PD; + view all Papageorgiou, N; Providência, R; Falconer, D; Wongwarawipat, T; Tousoulis, D; Lim, WY; Chow, AW; Schilling, R; Lambiase, PD; - view fewer (2020) Predictive role of BNP/NT-proBNP in non-heart failure patients undergoing catheter ablation for atrial fibrillation: An updated systematic review. Current Medicinal Chemistry , 27 (27) pp. 4469-4478. 10.2174/0929867326666191213095554.

Preview	Text (Article) Lambiase_BNPablation 20-04-2018 R1.pdf - Accepted Version Download (285kB) | Preview
Preview	Text (Figures) Lambiase_Figures Fin.pdf - Accepted Version Download (196kB) | Preview

Abstract

Atrial fibrillation (AF) is a growing public health issue, associated with significant morbidity and mortality. In addition to pharmacological therapy, catheter ablation is an effective strategy in restoring and maintaining sinus rhythm. However, ablation is not without risk, and AF recurs in a significant proportion of patients. Non-invasive, easily accessible markers or indices that could stratify patients depending on the likelihood of a successful outcome following ablation would allow us to select the most appropriate patients for the procedure, reducing the AF recurrence rate and exposure to potentially life-threatening risks. There has been much attention paid to brain natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) as possible predictive markers of successful ablation. Several studies have demonstrated an association between higher pre-ablation levels of these peptides, and a greater likelihood of AF recurrence. Therefore, there may be a role for measuring brain natriuretic peptides levels when selecting patients for catheter ablation.

Download activity - last month

Export as CSVJSONXML

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as CSVJSONXML

Archive Staff Only

View Item